This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Innovations of Jingfeng Song in Pharmaceutical Formulations
Introduction
Jingfeng Song is an accomplished inventor based in Waukegan, IL (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of peptide angiogenesis inhibitors. His work is instrumental in advancing medical treatments and improving patient outcomes.
Latest Patents
Jingfeng Song holds a patent for a pharmaceutical formulation comprising a peptide angiogenesis inhibitor. This patent focuses on parenteral formulations of peptides that are useful for sustained release. The methods of preparation for these formulations are also disclosed, showcasing his innovative approach to drug delivery systems.
Career Highlights
Jingfeng Song is associated with Abbott Laboratories Corporation, a leading global healthcare company. His role at Abbott has allowed him to work on cutting-edge research and development projects that aim to enhance therapeutic options for patients.
Collaborations
Some of his notable coworkers include Fortuna Haviv and Bryan K Erickson. Their collaborative efforts contribute to the innovative environment at Abbott Laboratories, fostering advancements in pharmaceutical science.
Conclusion
Jingfeng Song's contributions to pharmaceutical formulations highlight his expertise and dedication to improving healthcare solutions. His patent on peptide angiogenesis inhibitors exemplifies the impact of innovation in the medical field.